Prognostic factors in vulvar cancer patients: a single center experience
Abstract
Purpose: Many prognostic factors have been investigated in vulvar cancer patients. In our study, we aimed to
compare clinical and pathological prognostic factors and investigate the factors that affect the recurrence and
survival in patients with recurrent and non-recurrent squamous cell vulvar cancer.
Materials and methods: This retrospective study was conducted in Tepecik Research Hospital, Izmir, Turkey
between 1999-2020. The descriptive features, prognostic factors and survival in recurrent patients were
evaluated.
Results: Tumor invasion depth, surgical margin positivity, lymphovascular space invasion (LVSI), are
statistically significant for recurrence (p=0.03, p=0.00, p=0.04). Variables such as age, tumor size, surgical
margin distance (mm), tumor localization, presence of metastatic lymph node, operation type (surgery with
lymph node dissection) and adjuvant therapy were not found to be statistically significant in terms of recurrent
patients with vulvar cancer. There was correlation between recurrence, LVSI, surgical margin positivity, stage
and survival in Kaplan Meier survival analysis.
Conclusion: As in other studies, many prognostic factors like tumor invasion depth, surgical margin positivity,
LVSI are risk factors for recurrence in our study. Stage, LVSI, recurrence, surgical margin positivity were
significant factors for survival as well.
Keywords
References
- 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69: 7–34.
- 2. de Hullu JA, van der Zee AG. Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol 2006;60(1):38–58.
- 3. Zweizig S, Korets S, Cain J. Key concepts in management of vulvar cancer. Best Practice Res Clin Obstet Gynaecol 2014;28:959-966.
- 4. Tan A, Bieber AK, Stein JA, Pomeranz MK. Diagnosis and management of vulvar cancer: A review. J Am Acad Dermatol. 2019;81(6):1387-1396.
- 5. Baiocchi G, Silva Cestari FM, Rocha RM et al. Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system. Eur J Surg Oncol 2013;39(7):780–5.
- 6. Te Grootenhuis NC, van der Zee AG, van Doorn HC et al. Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen International Study on Sentinel nodes in Vulvar cancer (GROINSSV). Gynecol Oncol 2016;140(1):8-14.
- 7. Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-Pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynaecologic Oncol 1990;38:309-14.
- 8. Iversen T, Aalders JG, Christensen A. Squamous cell carcinoma of the vulva: a review of 424 patients, 1956–1974. Gynecol Oncol1980; 9:271–279.
- 9. Gadducci A, Tana R, Barsotti C, Guerrieri ME, Genazzani AR. Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva. Crit Rev Oncol Hematol 2012; 83(1):71-83.
- 10. Viswanathan AN, Pinto AP, Schultz D, Berkowitz R, Crum CP. Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol 2013;130(3):545-9.
